Vialwirebiotech, curated
July 22, 2026, 4:37 AM
June 24, 2026
- 4:31 AM · Drug Discovery World4:31 AMTRIMTECH raises $47m for protein degradation portfolio — Drug Discovery World
- 4:10 AM · Pharmaceutical Technology4:10 AMHaisco and Nuvectis sign licensing deal for two drugs — Pharmaceutical Technology
June 23, 2026
- 5:00 PM · MIT Technology Review5:00 PMEngineered “mini livers” could be injected as an alternative to transplantation — MIT Technology Review
- 5:00 PM · MIT Technology Review5:00 PMA breath test could diagnose pneumonia in minutes — MIT Technology Review
- 12:00 PM · BioWorld12:00 PMUS FDA approves 24 drugs in May in busiest month of 2026 — BioWorld
- 12:00 PM · BioWorld12:00 PMChina approves first CAR T for solid tumors — BioWorld
- 12:00 PM · BioWorld12:00 PMJ-Pharma drives first cancer LAT1 to phase III study with FDA nod — BioWorld
- 12:00 PM · BioWorld12:00 PMSK Biopharm taps Insilico in $2.5B AI CNS drug discovery deal — BioWorld
- 12:00 PM · BioWorld12:00 PMChina’s Micot targets HK$1.2B IPO to advance metabolic portfolio — BioWorld
- 12:00 PM · BioWorld12:00 PMCynata’s Cymerus flops in osteoarthritis, GVHD — BioWorld
- 12:00 PM · BioWorld12:00 PMPfizer ADC, from Seagen M&A, fails in phase III NSCLC trial — BioWorld
- 11:30 AM · Drug Discovery World11:30 AMCellares extends funding for cell therapy manufacturing — Drug Discovery World
- 10:59 AM · Drug Discovery World10:59 AMEC approves metastatic colorectal cancer combination regimen — Drug Discovery World
- 9:26 AM · Pharmaceutical Technology9:26 AMFDA changes rare disease tune again as it clears path for Regenxbio’s gene therapy — Pharmaceutical Technology
- 9:00 AM · BioWorld9:00 AMLys Therapeutics advances LYS-241 — BioWorld
- 9:00 AM · BioWorld9:00 AMZydus Lifesciences discloses new triglyceride-lowering agents — BioWorld
- 9:00 AM · BioWorld9:00 AMMatricelf studies neural tissue implant for spinal cord injury — BioWorld
- 9:00 AM · BioWorld9:00 AMK2 nabs two Antengene bispecific TCEs in $2B license, option deal — BioWorld
- 9:00 AM · BioWorld9:00 AMAnhorn Medicines gains IND clearance for neuroprotectant AH-008 — BioWorld
- 7:30 AM · STAT News
- 5:51 AM · Pharmaceutical Technology5:51 AMGenprex’s Reqorsa combo secures Canadian patent for lung cancer — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMKither completes Phase I trial of inhaled peptide therapy — Drug Discovery World
- 5:00 AM · Wired — Science5:00 AM3 People Have Gotten Cancer-Detecting Implants in Their Brains — Wired — Science
- 4:53 AM · Pharmaceutical Technology4:53 AMUS patent infringement investigation targets German drug price control measures — Pharmaceutical Technology
- 12:00 AM · FT — Pharmaceuticals12:00 AMEli Lilly deploys weight-loss cash on ‘App Store’ for scientists — FT — Pharmaceuticals
- 12:00 AM · FT — Pharmaceuticals12:00 AMEli Lilly deploys weight-loss cash on ‘App Store’ for scientists — FT — Pharmaceuticals
June 22, 2026
- 4:42 PM · SCMP — Tech4:42 PMUS-China rare earth clash 2.0? Fragile truce tested as tit-for-tat moves return — SCMP — Tech
- 4:39 PM · FT — Pharmaceuticals4:39 PMAbbVie buys Apogee for $10.9bn to acquire inflammatory disease drug — FT — Pharmaceuticals
- 12:00 PM · BioWorld12:00 PMDefinium’s phase III LSD Emerges as top MDD player — BioWorld
- 12:00 PM · BioWorld12:00 PMSCOTUS considers PhRMA challenge to trade secret disclosures — BioWorld
- 12:00 PM · BioWorld12:00 PMBionyra closes $165M series A to develop antibodies for inflammation — BioWorld
- 9:34 AM · PharmaVoice9:34 AMPfizer CFO departs for consumer goods sector — PharmaVoice
- 9:21 AM · PharmaVoice9:21 AMBacked by Sanofi and Roche, Orano Med chases radiopharma leadership — PharmaVoice
- 9:00 AM · BioWorld9:00 AMBioarctic and Lilly partner in neurodegeneration — BioWorld
- 9:00 AM · BioWorld9:00 AMGrant supports Replicate’s srRNA vaccine development for TB — BioWorld
- 7:49 AM · BioPharma Dive7:49 AMAbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs — BioPharma Dive
- 6:00 AM · Drug Discovery World6:00 AMElicio refines its Phase III strategy for ELI-002 7P in pancreatic cancer — Drug Discovery World
- 5:03 AM · Pharmaceutical Technology5:03 AMSun Pharma to acquire Innovcare Lifesciences for $28.7m — Pharmaceutical Technology